Gyre Therapeutics, Inc. (GYRE) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $106.00K; Additional Paid in CapitalUSD $240.64M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.49M; Retained Earnings (Accumulated Deficit)USD $-137.96M.
- 2026-03-31: Common Stock, Value, IssuedUSD $91.00K; Additional Paid in CapitalUSD $174.65M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $586.00K; Retained Earnings (Accumulated Deficit)USD $-77.67M.
- 2025-12-31: Common Stock, Value, IssuedUSD $91.00K; Additional Paid in CapitalUSD $172.82M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-908.00K; Retained Earnings (Accumulated Deficit)USD $-112.60M.
- 2025-09-30: Common Stock, Value, IssuedUSD $91.00K; Additional Paid in CapitalUSD $167.13M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.70M; Retained Earnings (Accumulated Deficit)USD $-66.70M.
Gyre Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Preferred Stock, Value, Issued USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Treasury Stock, Retired, Cost Method, Amount USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $106.00K | $240.64M | $1.49M | $-137.96M | $107.93M | $142.49M | 3 month · $1.83M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $91.00K | $174.65M | $586.00K | $-77.67M | $101.31M | $43.09M | 3 month · $2.83M | 3 month · $-8.00K | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $91.00K | $172.82M | $-908.00K | $-112.60M | $62.50M | $59.55M | 12 month · $7.16M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $91.00K | $167.13M | $-1.70M | $-66.70M | $101.92M | $137.41M | 3 month · $1.15M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $91.00K | $161.44M | $-2.29M | $-70.31M | $92.03M | $59.61M | 3 month · $1.12M | 3 month · $12.00K | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $87.00K | $138.18M | $-2.49M | $-70.75M | $68.12M | $40.67M | 3 month · $823.00K | 3 month · $-4.00K | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $86.00K | $136.19M | $-2.60M | $-73.45M | $63.32M | $35.79M | 12 month · $831.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $85.00K | $134.30M | $-946.00K | $-73.35M | $63.18M | $98.47M | 3 month · $237.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $85.00K | $133.66M | $-2.01M | $-74.48M | $60.35M | $93.35M | 3 month · $16.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $85.00K | $133.20M | $-1.74M | $-78.01M | $56.64M | $88.77M | 3 month · $11.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $77.00K | $68.18M | $-1.64M | $-85.54M | $-15.83M | $13.95M | 12 month · $7.28M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $37.00K | $384.89M | (m) | $-414.72M | $3.52M | $85.32M | 3 month · $98.00K | (m) | $33.31M | (m) | (m) | (m) | (m) |
| 2023-06-30 | $37.00K | $384.80M | (m) | $-413.15M | $-28.31M | $77.47M | 3 month · $89.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $37.00K | $384.69M | (m) | $-410.68M | $-25.95M | $77.33M | 3 month · $210.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $64.00K | $32.80M | $-392.00K | $7.39M | $42.52M | $72.22M | 12 month · $13.37M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $31.00K | $399.83M | (m) | $-370.48M | $29.38M | (m) | 3 month · $224.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $31.00K | $444.63M | (m) | $-365.60M | $79.06M | (m) | 3 month · $346.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $31.00K | $444.28M | (m) | $-417.23M | $27.08M | (m) | 3 month · $515.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $31.00K | $443.75M | (m) | $-402.69M | $41.09M | $59.47M | 12 month · $3.40M | (m) | (m) | (m) | (m) | 12 month · $3.56M | (m) |
| 2021-09-30 | $31.00K | $443.07M | $1.00K | $-382.37M | $60.74M | (m) | 3 month · $713.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $31.00K | $442.26M | $2.00K | $-357.13M | $85.16M | (m) | 3 month · $983.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $31.00K | $441.25M | $5.00K | $-337.20M | $104.09M | (m) | 3 month · $1.03M | (m) | (m) | (m) | (m) | 3 month · $3.56M | (m) |
| 2020-12-31 | $22.00K | $390.80M | $5.00K | $-314.76M | $76.07M | (m) | 12 month · $3.63M | (m) | (m) | (m) | (m) | 12 month · $4.56M | (m) |
| 2020-09-30 | $22.00K | $389.88M | $8.00K | $-295.85M | $94.06M | (m) | 3 month · $1.07M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $22.00K | $388.72M | $41.00K | $-279.82M | $108.96M | (m) | 3 month · $834.00K | (m) | (m) | (m) | (m) | 3 month · $2.04M | (m) |
| 2020-03-31 | $17.00K | $359.94M | $140.00K | $-262.57M | $97.52M | (m) | 3 month · $805.00K | (m) | (m) | (m) | (m) | 3 month · $2.51M | (m) |
| 2019-12-31 | $12.00K | $326.81M | $34.00K | $-258.52M | $68.34M | (m) | 12 month · $3.20M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $12.00K | $326.14M | $31.00K | $-244.91M | $81.27M | (m) | 3 month · $801.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $12.00K | $325.25M | $57.00K | $-232.20M | $93.11M | (m) | 3 month · $903.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $12.00K | $324.21M | $13.00K | $-218.43M | $105.81M | (m) | 3 month · $829.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $12.00K | $323.28M | $-4.00K | $-203.34M | $119.94M | (m) | 12 month · $2.61M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $12.00K | $322.47M | $-24.00K | $-192.50M | $129.95M | (m) | 9 month · $1.87M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $12.00K | $321.76M | $4.00K | $-184.81M | $136.96M | (m) | 3 month · $550.00K 6 month · $1.16M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $12.00K | $321.17M | $-4.00K | $-178.33M | $142.85M | (m) | 3 month · $606.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $6.00K | $204.26M | (m) | $-173.49M | $30.77M | (m) | 12 month · $863.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $4.00K | $192.62M | $4.00K | $-167.74M | $24.88M | (m) | 9 month · $556.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $4.00K | $192.29M | (m) | $-161.95M | $30.35M | (m) | 6 month · $231.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $2.00K | $165.95M | (m) | $-152.12M | $13.84M | (m) | 3 month · $120.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $1.00K | $164.05M | $-1.00K | $-147.98M | $16.07M | (m) | 12 month · $635.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $12.00K | $163.82M | $4.00K | $-144.23M | $19.60M | (m) | 9 month · $505.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $12.00K | $162.92M | $7.00K | $-139.46M | $23.48M | (m) | 6 month · $318.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $11.00K | $162.60M | $4.00K | $-134.63M | $27.99M | (m) | 3 month · $153.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $1.00K | $162.46M | $1.00K | $-131.04M | $31.43M | (m) | 12 month · $326.00K | (m) | (m) | 12 month · $774.00K | (m) | 12 month · $96.00K | (m) |
| 2015-09-30 | $11.00K | $162.09M | $16.00K | $-125.91M | $36.21M | (m) | 9 month · $135.00K | (m) | (m) | 9 month · $774.00K | 9 month · $82.00K | 9 month · $96.00K | (m) |
| 2015-06-30 | $9.71M | $7.01M | $11.00K | $-120.86M | $-113.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $34.00K | $423.18M | $23.00K | $-320.01M | $103.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $9.71K | $6.92M | $4.00K | $-116.28M | $-109.35M | (m) | 12 month · $244.00K | (m) | (m) | (m) | (m) | 12 month · $28.00K | 12 month · $3.41M |
| 2014-09-30 | $34.00K | $421.45M | $55.00K | $-308.63M | $112.91M | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2014-06-30 | $34.00K | $420.64M | $110.00K | $-303.77M | $117.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $34.00K | $419.63M | $66.00K | $-295.63M | $124.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $9.56K | $6.64M | $87.00K | $-109.66M | $-103.01M | (m) | 12 month · $298.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $34.00K | $413.87M | $95.00K | $-267.27M | $146.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $34.00K | $412.53M | $-14.00K | $-254.37M | $158.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $34.00K | $411.23M | $188.00K | $-241.99M | $169.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $34.00K | $409.61M | $201.00K | $-233.93M | $-93.34M | (m) | 12 month · $7.85M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $34.00K | $408.22M | $377.00K | $-218.06M | $190.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $33.00K | $406.31M | $194.00K | $-210.18M | $196.36M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $33.00K | $403.11M | $227.00K | $-224.67M | $178.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $33.00K | $401.15M | $36.00K | $-226.93M | $174.29M | (m) | 12 month · $8.51M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $33.00K | $399.12M | $-19.00K | $-217.12M | $182.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $33.00K | $396.94M | $199.00K | $-208.07M | $189.10M | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $29.00K | $309.99M | $225.00K | $-218.40M | $91.85M | (m) | 12 month · $4.94M | (m) | $0.00 | (m) | (m) | (m) | 12 month · $3.50M |
| 2009-12-31 | (m) | (m) | (m) | (m) | $68.99M | (m) | 12 month · $2.45M | (m) | (m) | (m) | (m) | (m) | 12 month · $41.00K |
| 2008-12-31 | (m) | (m) | (m) | (m) | $57.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |